Through Dr. Frits van Rhee's diligent attraction and research, helium has made a important interaction connected improving the lives of those affected by aggregate myeloma.
Dr. Frits van Rhee is simply a prof of medicine and objective manager of the University of Arkansas for Medical Sciences (UAMS) Myeloma Center. Through his diligent attraction and research, helium has made a important interaction connected improving the lives of those affected by aggregate myeloma.
While the UAMS Myeloma Center has made a batch of advancement in30-plus years successful the attraction of myeloma, van Rhee continues to some beforehand the attraction of patients and widen their lives.
“We person already established, done our semipermanent follow-up attraction data, that myeloma patients tin beryllium cured,” van Rhee has said. He besides believes the aboriginal looks brighter than ever, with the adjacent 30 years holding large committedness for his patients with myeloma.
In precocious 2021, nether van Rhee’s leadership, the UAMS Myeloma Center became — and contiguous remains — the archetypal and lone aesculapian installation successful Arkansas to connection the cutting-edge attraction of chimeric antigen receptorT-cell immunotherapy. For astir each patients who person received the attraction truthful far, the results person been remarkable.
Van Rhee earned his aesculapian grade from Erasmus University successful Rotterdam, Netherlands, and his Ph.D. astatine the Imperial College of Science, Medicine and Technology astatine University of London. Van Rhee trained successful interior medicine and hematology successful the UK, and successful bony marrow transplantation astatine John Radcliffe Hospital successful Oxford and the Royal Postgraduate Medical School successful London. He holds the Charles &ClydeneScharlau Chair for Hematological Malignancies Research. He is an planetary adept connected Castleman disease, with 1 of the largest populations of patients with Castleman illness successful the world.
He besides is an adept successful aggregate myeloma and different hematologic malignancies, with a probe absorption successful immunotherapy. Van Rhee is simply a subordinate of the International Society for Cellular Therapy, the International Society for Experimental Hematology, the European Group for Bone and Marrow Transplantation, the Royal College of Physicians (UK), the Royal College of Pathologists (UK) and the American Society of Hematology. He has UK committee certification successful interior medicine and hematology.
English (US)